21/22 - Pharmacotherapy ACS Flashcards

1
Q
  • *STEMI** + nonPCI
  • *Fibronolytic (>12 hours)_ or _nonprimary PCI**

What P2Y12 Inhibitor do we use?

“DAPT - Dual Antiplatelet Therapy”
Aspirin + P2Y12 Antagonist

A

CLOPIDOGREL
preferred if higher bleeding risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ACS Secondary Prevention Therapy

1st 24 Hours

A

ABS

Aspirin
indefinitely

  • *Beta Blocker**
  • *~3 years** / indefinitely if LVEF < 40%

STATIN
indefinitely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

N-STEMI** + **Conservative

What P2Y12 Inhibitor do we use?

“DAPT - Dual Antiplatelet Therapy”
Aspirin + P2Y12 Antagonist

(Ischemia Driven)

A

CLOPIDOGREL

or

TICAGRELOR
need to limit aspirin < 100 mg daily
doses > 300 = ↑mortality risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ACS Secondary Prevention Therapies

STATINS

A

ALL PATIENTS w/ ACS

  • *HIGH INTENSITY STATIN**
  • *Atorvastatin 80mg** (40mg) or Rosuvastatin 40mg (20mg)
  • may use moderate-intensity if risk for ADR*

ADR:
LFT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ACS Secondary Prevention Therapy

PRIOR TO DISCHARGE

A
  • *DAPT**
  • *Aspirin + P2Y12 Inhibitor**

STATIN** + **BETA BLOCKER

SL NTG
PRN

ACE / ARB / EPLERENONE

discontinue NSAIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical Suspicion of ACS + Ischemic Symptoms >10 min
VVV
ECG / Enzymes (CTN) / St-segment Monitoring
VVV
Initial Treatment
VVV
ACUTE SUPPORTIVE CARE

A

ANO + MBC

Aspirin** + **Oxygen** + **SL NTG

MORPHINE
For symptoms refractory to NTG

  • *Beta Blockers**
  • *PO** –> IV if ↑BPor ↑HR

CCBs
mainly if CI to BBs –> asthma / cocaine induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Reperfusion Strategy:
FIBRINOLYTICS
TPA = Alteplase / RPA = Reteplase / TNK = Tenecteplase

ABSOLUTE CONTRAINDICATIONS

A

BP > 220/110

STROKE 3 months

Active Bleeding / Bleeding Disorder

Recent Head Trauma / Previous Intracranial Hemorrhage

Intracranial MASS or AVM

Intracranial / Intraspinal SURGERY < 2 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

STEMI** + **PCI = Any of the 3

+ High Risk Patient = Diabetes

What P2Y12 Inhibitor do we use?

“DAPT - Dual Antiplatelet Therapy”
Aspirin + P2Y12 Antagonist

A

avoid Clopidogrel

PRASUGREL
AVOID if: <60kg / >75yo / Hx TIA-Stroke

TICAGRELOR
Limit aspirin dose < 100mg
possible CABG in future / unknown coronary anatomy
ticagrelor is REVERSIBLE, unlike clopidogrel & prasugrel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Reperfusion Strategy:
FIBRINOLYTICS
TPA = Alteplase / RPA = Reteplase / TNK = Tenecteplase

ADR’s / Risk Factors

A

BLEEDING / STROKE
specifically INTRACRANIAL BLEEDING

Risk Factor:
Age > 65

Wt < 70kg

Uncontrolled HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical Suspicion of ACS + Ischemic Symptoms >10 min
VVV
FIRST STEPS

A

12-Lead ECG
within 10 minutes

Serial cTn Levels
Cardiac Enzymes = Troponin & CK-MB

Continuous ST-segment MONITORING

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

AntiCoagulant Therapy

When would we use FONDAPARINUX?

&

When to AVOID?

A

LEAST USED

Preferred for:
Conservative Strategy** + **HIGH RISK FOR BLEEDING

Avoid if:

  • *Cath/PCI performed** - associated w/ cath thrombosis
  • *CrCl < 30**
  • *Weight < 50kg**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

STEMI** + **PCI = Any of the 3

+Possible CABG in future

What P2Y12 Inhibitor do we use?

“DAPT - Dual Antiplatelet Therapy”
Aspirin + P2Y12 Antagonist

A

TICAGRELOR
Limit aspirin dose < 100mg
possible CABG in future / unknown coronary anatomy

Because:

  • *Ticagrelor** is REVERSIBLE, unlike clopidogrel/prasugrel
  • *NO NEED to stop 5-7 days b4 CABG**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

N-STEMI** + **INVASIVE PCI
+
Normal cTn & NO ischemic ECG changes

What P2Y12 Inhibitor do we use?

“DAPT - Dual Antiplatelet Therapy”
Aspirin + P2Y12 Antagonist

A

ANY OF THE 3

CLOPIDOGREL
good for higher bleeding risk

PRASUGREL
Avoid if: <60kg / >75yo / hx Stroke-TIA

TICAGRELOR
need to limit aspirin < 100 mg daily
doses > 300 = ↑mortality risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical Suspicion of ACS + Ischemic Symptoms >10 min
VVV
ECG / Enzymes (CTN) / St-segment Monitoring
VVV
INITIAL TREATMENT

A

A - N - O

ASPIRIN
All patients –> 162-325mg for 1 dose = Chew for RAPID absorption
81mg QD indefinitely

  • *SL NTG**
  • *q5 min PRN** (<3 doses)

Oxygen
if O2 Sat < 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AntiCoagulant Therapy

When would we use HEPARIN = UFH?

&

When to AVOID?

A

MOST COMMONLY USED = Cheap
B4/during PCI
Fibrinoytic STEMI
Intermediate-High Risk ACS

Weight Based Dosing:
60u/kg (max = 4k) IVP –> 12u/kg/hr (max = 1k)
adjusted to maintain:
aPTT ~60-80 seconds

Duration = 48 hours or after PCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

AntiCoagulant Therapy

When would we use BIVALIRUDIN?

&

When to AVOID?

A

INVASIVE PCI STRATEGY
usually until PCI is completed & up to 72hours after PCI

Do not use when:
NO PCI planned

need for GP IIB/IIIa Inhibitor​ in most cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

STEMI

Reperfusion Therapy

Goal for reperfusion (STEMI):

30 minutes door to drug (thrombolytics)

90 minutes door-to-balloon (primary PCI)

A

Preferred = INVASIVE Therapy:

  • *PRIMARY PCI**
  • lower mortality vs fibronolysis*
  • *Angiogram first** = gold standard to diagnose CAD

If PCI can NOT be performed <120 minutes:
FIBRONOLYTICS
TPA / RPA / TNK (-eplase)

18
Q

Acute Supportive Care for ACS

Calcium Channel Blockers

Indication / Cautions

A
  • *Diltiazem_ / _Verapamil**
  • Vasodilate / ↓*HR/↓ Contractility

RARELY USED BUT MAINLY FOR:
Refractory / Contraindicated to B-Blockers

ASTHMA** / **COPD

Tachycardia** due to **AFIB/Flutter

Cocaine-induced

19
Q

Acute Supportive Care for ACS

NITROGLYCERIN

Indication / Cautions

A

SL Initial –> IV or Topical if Symptoms persist

  • *Titrate to Pain Relief & BP**
  • *SBP > 90-100**mmHg

Adr:
HypoTension / Tachycardia / Headache

AVOID:

  • *RIGHT VENTRICULAR INFARCT**
  • *PDE Inhibitors**:
  • *Viagra/Levitra - 24 hrs** // Tadalafil - 48 hours
20
Q

STEMI** + **PCI = Any of the 3

<60 kg or >75yo or Hx TIA or STROKE

What P2Y12 Inhibitor do we use?

“DAPT - Dual Antiplatelet Therapy”
Aspirin + P2Y12 Antagonist

A
  • AVOID PRASUGREL*
  • <60 kg or >75yo or Hx TIA or STROKE*

TICAGRELOR** or **CLOPIDOGREL

21
Q

STEMI** + **PCI = Any of the 3

+ High Bleeding Risk

What P2Y12 Inhibitor do we use?

“DAPT - Dual Antiplatelet Therapy”
Aspirin + P2Y12 Antagonist

A

CLOPIDOGREL
preferred if higher bleeding risk

22
Q

ACS

What LABS must be gathered?

A

PTT + CBC + BUN + CR

Lipid profile

  • *Coagulation** profile:
  • *PTT** + INR

CBC
Hgb / Hct / Platelets

Chem 7:
electrolytes + BUN** + **Cr

23
Q

AntiCoagulant Therapy

When would we use LMWH?
Enoxaparin 1mg/kg SC q12
// dalteparin 120 iu/kg q12 SC

&

When to AVOID?

A
  • *STEMI_ + _FIBRINOLYTIC**
  • non invasive treatment strategy*
  • N-STEMI** + *noPCI

Consider ALTERNATIVE if:
Bleeding risk –> Fonda
Renal Insufficiency –> UFH(heparin)
Obesity –> Fonda/heparin

24
Q

Symptoms of ACS

A

Hx of + risk factors for CAD

Symptoms:
Classical CAD symptoms
may occur @rest or with exercise
LITTLE or NO relief with
REST +/- NTG

LAST > 20 MINUTES
regular angina = 3-5 min

25
_Acute Supportive Care for ACS_ ## Footnote **_BETA BLOCKERS_** **Indication / Cautions**
**_PO within 24 hours_** **_Consider IV if_**: ↑**BP** or ↑**HR** Avoid if: **_CHF**_ / _**Heart Block**_ / _**ASTHMA_** / **COPD-WHEEZING** & **_RISK OF CARDIOGENIC SHOCK_** **\> 70** / **BP \<120mmHg** / **HR \>110** or **\<60** long time since Sx onset
26
_Acute Supportive Care for ACS_ ## Footnote **_NITROGLYCERIN_** **WHEN TO AVOID?**
AVOID: * *_RIGHT VENTRICULAR INFARCT_** * *PDE Inhibitors**: * *Viagra/Levitra - 24 hrs** // **Tadalafil - 48 hours** **_SBP \<90**_ or _**HR \< 50_**
27
**ACS** **Diagnostic & Baseline Workup**
**_PHYSICAL EXAM_** Need to see evidence of **_HEART FAILURE_** / **Pulmonary Edema** **_Cardiac Monitor_** Vitals / Arrythmia monitoring **_Serial 12 Lead ECGs_**
28
ACS Antiplatelet Therapy **_Glycoprotein IIb/IIa Inhibitors_** Eptifibatide / Tirofiban = Renal Abciximab **WHEN WOULD WE AVOID / CONTRAINDICATIONS**
* _NOT RECOMMENDED WHEN:_* * *Bivalirudin** used * *Fibronolytic (-plase's)** _PRECAUTIONS:_ **CrCl \< 30mL/min** or **Hemodialysis**
29
**Which Drug do we have to AVOID if** **_CARDIOGENIC SHOCK_** risk or Presence **& What are those risks?**
**_BETA BOCKERS -olols_** **Age \> 70** **Systolic BP \< 120**mmhg **60\< HR \>110** Also: **Asthma / COPD / Wheezing _HEAR FAILURE**_or_**HEART BLOCK_**
30
ACS Antiplatelet Therapy **_Glycoprotein IIb/IIa Inhibitors_** Eptifibatide / Tirofiban = Renal Abciximab **WHEN WOULD WE USE?**
*NOT commonly used* * *_ACS undergoing PCI_** * not used w/o PCI* Also: GP IIB/IIa Inhibitor OR Cangrelor if.. **_If NO P2Y12 used prior to PCI_** * _DO NOT USE IF:_* * *Bivalirudin** used / **Fibronolytic Therapy** * *CrCl \< 30mL** or **Hemodialysis**
31
_ACS Secondary Prevention Therapies_ **When would we use a ACE/ARB?**
_**ALL PATIENTS** - **POST MI**_ Strongest evidence if: * *_LVEF**_ _**\<**_ _**40%_** * indefinitely* ***3mo if Anterior MI*** ADR: **HyperKalemia + Renal Dysfunction**
32
**_N-STEMI**_ + _**INVASIVE PCI_** + _**↑****cTn Levels**or**Ischemic ECG changes**_ **What P2Y12 Inhibitor do we use?** "DAPT - Dual Antiplatelet Therapy" Aspirin + P2Y12 Antagonist
**_PRASUGREL_** Avoid if: **\<60kg** / **\>75yo** / **hx Stroke-TIA** or **_TICAGRELOR_** need to limit **aspirin \< 100 mg daily** doses \> 300 = ↑mortality risk
33
_ACS Secondary Prevention Therapies_ **When would we consider** **EPLERENONE \> Ace/Arb** (Anti Aldosterone)
**_SYMPTOMATIC HF_** or **Post MI + low LVEF** & **_DIABETES_** ADR: **HYPERKalemia** \> 10% incidence over ACE/Arm **CONTRAINDICATED if CrCl \<30mL/min**
34
_Acute Supportive Care for ACS_ ## Footnote **_Morphine Sulfate_** **Indication / Cautions**
**1-8 mg** **IVP q5-15min** * *_Symptoms REFRACTORY to NTG_** * *Anxiolytic** / **Analgesic** / IV --\> Vasodilator Cautions: **Respiratory Depression** & **HypoTension**
35
**How LONG do we use DAPT (Dual Antiplatelet Therapy)** **_P2Y12 Antagonist Therapy?_** + **Special Considerations**
**_\> 12 MONTHS_** **_STOP DRUG 5-7 DAYS B4 CABG_** Clopidogrel / Prasugrel = IRREVERSIBLE inhibitors **_14 days for STEMI + FIBRONOLYTIC_**
36
**Which drug can we NOT use if the patient had a:** **_PREVIOUS STROKE?_**
**_FIBRONOLYTICS_** **Alte**plase / **Rete**plase / **Tenect****e**plase Contraindicadted for recent STROKE \< 3 months * *_PRASUGREL_** * *\<60kg** // **\>75years** * *Hx TIA** or **STROKE**
37
**Reperfusion Strategy: _FIBRINOLYTICS_** TPA = Alteplase / RPA = Reteplase / TNK = Tenecteplase ## Footnote **INDICATIONS**
**_STEMI**_ + _**PCI can NOT be performed \< 120 minutes_** Indications: **_Hx consistant with AMI/Angina**_ within _**\<12 hours of Sx onset_** *no mortality benefit if start \> 12 hours after Symptoms* + **_EKG_** shows **_ST ELEVATION_** \>1mV / **new onset LBBB** left bundle branch block + **_Elevated Enzymes_** --\> to confirm (CK-MB +/- Troponin)
38
_Risk Calculator in ACS Patients_ * *_TIMI SCORE_** * there is also = GRACE & HEART* scores * *_TIMI Risk level: score (MACE %)_** * *Low: 0–2** (4.7–8.3%) * *Intermediate: 3–4** (13.2–18.9%) * *High: 5–7** (26.2–40.9%)
**HEAT-R** * *_History_** * *_\>_** **2 events/24hrs** or **known CAD** (**\>50% block)** or **Aspirin use \<7d** * *_ECG_** * *ST Changes** **_Age**_ _**\>_** **65y/o** **_↑Troponin_** **_Risk Factors**_ _**\>_** **3RFs**
39
Reperfusion Strategy: **_FIBRINOLYTICS_** TPA = Alteplase / RPA = Reteplase / TNK = Tenecteplase ## Footnote **Relative Contraindications**
**_BP \> 180/100_** Taking **_Oral Anticoagulants_** Recent **Trauma / Surgery \< 2 weeks** Hx of **GI/GU Surgery** **\<6 months** **Active PUD**
40
**What drug must we: LIMIT Aspirin Dose \< 100mg?**
**_TICAGRELOR_** P2Y12 Antagonist Doses **\>300 = ↑Mortality Risk**